NCT02049489 A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma Status COMPLETED Phase PHASE1
NCT02047214 Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy Status TERMINATED Phase PHASE2
NCT02029573 Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma Status COMPLETED Phase PHASE2
NCT02026271 A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma Status COMPLETED Phase PHASE1
NCT02022384 Immunophenotyping From Blood of Patients With Malignant Gliomas Status COMPLETED Phase N/A
NCT02017249 Efficacy Study of Oral Arginine to Improve Immune Function in Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT02010606 Phase I Study of a Dendritic Cell Vaccine for Patients With Either Newly Diagnosed or Recurrent Glioblastoma Status COMPLETED Phase PHASE1
NCT02006563 Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors Status COMPLETED Phase N/A
NCT01985256 Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor Status COMPLETED Phase PHASE1
NCT01933815 Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma Status SUSPENDED Phase PHASE1/PHASE2
NCT01931098 Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab Status COMPLETED Phase PHASE2
NCT01929720 Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors Status COMPLETED Phase NA
NCT01923922 CT Perfusion in the Prognostication of Cerebral High Grade Glioma Status COMPLETED Phase NA
NCT01902771 Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors Status TERMINATED Phase PHASE1
NCT01884740 Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22 Status TERMINATED Phase PHASE1/PHASE2
NCT01873469 Impact of [11C]-Methionine PET/MRI for Individual Tailoring Postoperative Radiochemotherapy for Glioblastoma Multiforme Status COMPLETED Phase N/A
NCT01865162 Ketogenic Diet as Adjunctive Treatment in Refractory/End-stage Glioblastoma Multiforme: a Pilot Study Status COMPLETED Phase PHASE1
NCT01856933 BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM) Status COMPLETED Phase PHASE2